Sharda Cropchem Q1 FY27 Earnings Call — Analysis (NSE: SHARDACROP)

Sharda Cropchem Q1FY27 revenue up 9% YoY with EBITDA rising 25% on improved product mix, while Europe volumes dipped temporarily due to a heatwave, and management maintained full-year guidance.

4 Aug 2026 · Analysis by Alpha Inflection

The take

Q1FY27 Revenue ₹1,074 Cr ( +9% YoY ) . New guidance — FY27 group revenue 10-15% . New story: Registration pipeline as growth moat .

Results

Revenue ₹1,074 Cr +9% YoY; EBITDA ₹178 Cr +25% YoY; EBITDA margin 16.6% (+220bps); PAT ₹88 Cr impacted by lower forex gains (₹7.5 Cr vs ₹73.1 Cr in Q1FY26); underlying PBT excl forex grew 16% YoY.

Financial highlights

Guidance

FY27 guidance retained: 10-15% revenue growth, ~35% gross margins, 18-20% EBITDA margins, 5-10% volume growth; Europe volumes expected to recover in coming quarters.

What management committed to

• Sharda Cropchem will achieve 10-15% revenue growth in FY27. — 10-15%, FY27
• Sharda Cropchem expects volume growth of 5-10% in FY27. — 5-10%, FY27
• Gross margins in FY27 will be approximately 35%, with a range of 35-37%. — 35-37%, FY27
• EBITDA margins in FY27 will be in the range of 18-20%. — 18-20%, FY27
• Registration-related capex for FY27 will be around ₹500 Cr, within a range of ₹480-550 Cr. — ₹480-550 Cr, FY27
• Annual depreciation for FY27 will be approximately ₹370-375 Cr. — ₹370-375 Cr, FY27
• Effective tax rate on an annualized basis for FY27 will be 18-20%. — 18-20%, FY27
• Volumes in Europe will recover in the coming quarters after the Q1FY27 dip caused by distributor cutbacks from the heatwave. — Q2-Q4FY27
• Pricing across markets is stabilizing and slowly improving after a severe beating two years ago.

Key themes

Registration pipeline, margin expansion, Europe recovery

How the narrative shifted

• Registration pipeline as growth moat: Management stresses that continued heavy investment in product registrations (₹450-500 Cr annually) is the foundation of future growth, despite recent slow additions and inherent uncertainties.
• Europe temporary volume dip, margin resilience: A heatwave caused distributor cutbacks, but agrochemical gross margins in Europe actually improved; recovery is already underway and volumes expected to normalize.
• LATAM & NAFTA as growth engines: LATAM sustained momentum as a strong growth engine; NAFTA delivered both top-line growth and sharp margin expansion, compensating for Europe's softness.
• Forex volatility masks operating performance: Large unrealized forex gains/losses from EUR/USD revaluation of trade receivables/payables distort reported PAT; underlying PBT growth (ex-FX) is the true performance indicator.
• Pricing recovery underway: After a severe pricing downturn two years ago, prices have stabilized and are slowly improving, supporting margin outlook.
• Asset-light China sourcing model: 100% contract manufacturing from China keeps the balance sheet light but exposes the company to geopolitical/supply-chain risks; management downplays discussion of import dependency.

Operational commentary

• Total product registrations reached 3,016 as of 30-Jun-2026 (up from 3,011 on 31-Mar-2026), with 1,027 applications at approval stage globally.
• Europe volumes declined temporarily due to distributor cutbacks driven by an unusual heatwave; however, agrochemical gross margins in Europe improved to 44.2% (Q1FY26: 42.9%).
• LATAM remained a strong growth engine; NAFTA and Rest of World also delivered growth with better profitability.
• NAFTA gross margins expanded sharply to 32.8% (Q1FY26: 25.9%); LATAM gross margins declined to 16.9% (Q1FY26: 28%) due to product mix.
• Working capital days improved by 10 days QoQ to 88 days; company remains debt-free.
• Q1 registration-related capex was unusually high at ₹273 Cr due to one-time data compensation payments; annual guidance of ~₹500 Cr unchanged (range ₹480-550 Cr).
• Pricing across markets is stabilizing and slowly improving after a severe downturn two years ago.
• New product introductions are contributing to better margins, though near-term volume impact is limited; registrations remain the primary growth driver.

Analyst Q&A

• Q. What is the revenue growth split into volume, forex, and realization?

  Volume growth -1.6%, FX impact +12.7%, product mix impact -2.1%, total +9%.

• Q. Why does product mix improvement not reflect in realization growth given higher-value products?

  You have to look at overall picture; geographic mix, particularly Europe degrowth vs other regions, will improve in coming quarters.

• Q. Details on the large forex gain in Q1FY26 and accounting treatment.

  The gain was mostly unrealized from repricing foreign currency receivables/payables due to sudden 10% appreciation of Euro vs USD; current quarter had only 1% move. Explained that EBITDA excludes forex.

• Q. Will registration capex guidance be revised upward after ₹273 Cr spend in Q1?

  No revision; Q1 was unusual due to heavy data compensation payments not repeating; full-year could be ₹480-550 Cr.

• Q. What is driving strong LATAM and NAFTA growth, and can it sustain?

  I am giving you the total picture and you have to just be satisfied with the total picture rather than going too much into the details.

• Q. Can you provide new product revenue contribution or an internal benchmark?

  New products contribute to better margins but immediate quantity impact is lesser; we don't know how many registrations we will get due to uncertainties.

• Q. Pricing trends across markets — is pricing improving sequentially?

  Yes, prices are improving; they took a severe beating 2 years back, stabilized, and are now slowly improving.

View source

Research and educational content only. Not investment advice.